Ever wondered why your body clock seems to go haywire when you work shifts? It turns out, the math models that predict our internal rhythms do well in labs but struggle in the real world. This is especially true for shift workers whose light exposure is all over the place. Researchers dug into this
After nearly five years, authorities have finally made an arrest in the case of the pipe bombs found near the U. S. Capitol on January 5, 2021. The suspect, a 30-year-old man from Prince William County, Virginia, is now in custody. This arrest brings a significant development to one of the lingering
Vibrio parahaemolyticus is a tricky bacteria that can make people sick. To tackle it, scientists need to know how well different medicines work against it. They tested eight medicines using a standard method. They did this in different labs and at two different temperatures: 35°C and 28°C. The resul
Big tech companies are spending a fortune on AI. They're building supercomputers and data centers. But where will the money come from? Some companies are spending more than they make. If AI loses its shine, the economy could take a big hit. AI is everywhere. It's changing how we learn, work, and cr
The Little Rock Board of Directors recently turned down a proposal that aimed to bring more openness about the police department's use of surveillance tools. This decision has sparked discussions about transparency and community trust. The rejected ordinance, backed by At-Large Director Antwan Phil
QC Ally has welcomed Scott Ingram as their new Chief Information Officer. With over 20 years of experience, Scott is an expert in cybersecurity, cloud infrastructure, and enterprise technology. He has worked in the mortgage, fintech, and global tech industries. Scott's new role involves leading tec
A sneaky new malware called Albiriox is out there, and it's giving hackers full control over Android phones. It's not just about stealing data; this malware lets attackers use your phone as if they were holding it. It first showed up in September 2025 and went public in October 2025. Experts think R
Cancer is a tricky foe. It has some common traits, but finding shared molecular patterns across different types has been a challenge. Now, with tons of data at hand, researchers are diving deep to uncover these hidden links. A recent study took a big leap. They looked at data from twelve different
Black Diamond Therapeutics has shared some promising news about their drug, silevertinib. It's being tested on people with a specific type of lung cancer. The results from the second phase of trials show that 60% of patients responded well to the treatment. This includes 25 partial responses and one
In a twist of fate, a vaccine meant for shingles might also be a secret weapon against dementia. Researchers stumbled upon this clue while studying data from Wales, where a strict age rule for the shingles vaccine created a unique scenario. People born in a specific year got the shot, while those bo
